Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Nanomedicine: current status and future prospects.

Moghimi SM, Hunter AC, Murray JC.

FASEB J. 2005 Mar;19(3):311-30. Review.

PMID:
15746175
2.

Second world conference on nanomedicine and drug delivery.

Ninan N, Thomas S, George A, Sebastian M.

Ther Deliv. 2011 Jun;2(6):711-5.

PMID:
22822503
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Cancer nanotechnology: small, but heading for the big time.

[No authors listed]

Nat Rev Drug Discov. 2007 Mar;6(3):174-5. No abstract available.

PMID:
17396287
5.

Porous nanoparticles in drug delivery systems.

Arayne MS, Sultana N.

Pak J Pharm Sci. 2006 Apr;19(2):158-69. Review.

PMID:
16751130
6.

Unique benefits of nanotechnology to drug delivery and diagnostics.

McNeil SE.

Methods Mol Biol. 2011;697:3-8. doi: 10.1007/978-1-60327-198-1_1.

PMID:
21116949
7.

Targeted drugs and nanomedicine: present and future.

Debbage P.

Curr Pharm Des. 2009;15(2):153-72. Review.

PMID:
19149610
8.

Nanosize drug delivery system.

Mukherjee B.

Curr Pharm Biotechnol. 2013;14(15):1221.

PMID:
25106648
9.

Toward the emergence of nanoneurosurgery: part II--nanomedicine: diagnostics and imaging at the nanoscale level.

Leary SP, Liu CY, Apuzzo ML.

Neurosurgery. 2006 May;58(5):805-23; discussion 805-23. Review.

PMID:
16639314
10.

Nanomedicine-nanoscale drugs and delivery systems.

Singh S.

J Nanosci Nanotechnol. 2010 Dec;10(12):7906-18. Review.

PMID:
21121278
11.

Magnetic targeting for site-specific drug delivery: applications and clinical potential.

Polyak B, Friedman G.

Expert Opin Drug Deliv. 2009 Jan;6(1):53-70. doi: 10.1517/17425240802662795 . Review.

PMID:
19236208
12.

Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.

Bharali DJ, Mousa SA.

Pharmacol Ther. 2010 Nov;128(2):324-35. doi: 10.1016/j.pharmthera.2010.07.007. Epub 2010 Aug 10. Review.

PMID:
20705093
13.

Nanomedicine in otorhinolaryngology: what does the future hold?

Philpott CM, Gane S, McKiernan D.

Eur Arch Otorhinolaryngol. 2011 Apr;268(4):489-96. doi: 10.1007/s00405-010-1418-5. Epub 2010 Nov 27. Review.

PMID:
21113606
14.

Is nanotechnology ready for primetime?

Brower V.

J Natl Cancer Inst. 2006 Jan 4;98(1):9-11. No abstract available.

PMID:
16391365
15.

Nanostructure-mediated drug delivery.

Hughes GA.

Nanomedicine. 2005 Mar;1(1):22-30. Review.

PMID:
17292054
16.

Emerging trends of nanomedicine--an overview.

Sandhiya S, Dkhar SA, Surendiran A.

Fundam Clin Pharmacol. 2009 Jun;23(3):263-9. doi: 10.1111/j.1472-8206.2009.00692.x. Review.

PMID:
19527298
17.

Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.

Gaumet M, Vargas A, Gurny R, Delie F.

Eur J Pharm Biopharm. 2008 May;69(1):1-9. Epub 2007 Aug 7. Review.

PMID:
17826969
18.

Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances.

Liu Y, Lou C, Yang H, Shi M, Miyoshi H.

Curr Cancer Drug Targets. 2011 Feb;11(2):156-63. Review.

PMID:
21158720
19.
20.

Supplemental Content

Support Center